NASDAQ:TCRX

News

Morgan Stanley analysts downgrades an Equal-weight rating for Tscan Therapeutics Inc (TCRX)

Roman Campbell

Tscan Therapeutics Inc’s recently made public that its 10% Owner Lynx1 Capital Management LP acquired Company’s shares for reported $71974.0 ...

Insiders Updates

Morgan Stanley’s latest rating for TCRX stock

Roman Campbell

Tscan Therapeutics Inc’s recent filing unveils that its 10% Owner Lynx1 Capital Management LP acquired Company’s shares for reported $71974.0 ...

News

Tscan Therapeutics Inc [TCRX] Stock bought by Insider Lynx1 Capital Management LP for $71974.0

Jaxson Clark

Tscan Therapeutics Inc’s recently made public that its 10% Owner Lynx1 Capital Management LP acquired Company’s shares for reported $71974.0 ...

Insiders Updates

Tscan Therapeutics Inc [NASDAQ: TCRX] Sees Increase in Stock Value

Jaxson Clark

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or ...

Knox Daily
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.